(redirected from atrial tachycardia)
Also found in: Dictionary, Medical, Acronyms, Encyclopedia.
Graphic Thesaurus  🔍
Display ON
Animation ON
  • noun

Words related to tachycardia

abnormally rapid heartbeat (over 100 beats per minute)

References in periodicals archive ?
Focal atrial tachycardia originating from the right atrial appendage:First successful cryoballoon isolation.
The common types of narrow complex tachycardia are atrioventricular nodal tachycardia, atrioventricular reentrant tachycardia and atrial tachycardia.
Atrial tachycardia is caused by rapid discharge of an abnormal atrial focus or by re-entry.
The diagnostic electrophysiological study was done which confirmed a left sided accessory pathway or ectopic atrial tachycardia focus in all cases.
Multifocal atrial tachycardia (FIGURE 3) is a supraventricular arrhythmia with [greater than or equal to] 3 different P wave morphologies, as well as varying PR and RR intervals on the 12-lead EKG.
Multiple stimuli from different parts of the atria cause atrial tachycardia.
Primary endpoints are freedom from any atrial fibrillation, atrial tachycardia, pulmonary vein stenosis and procedure time.
Hypokalaemia (<3 mmol/l) increases the cell membrane potential and is associated with delayed conduction causing atrial and ventricular ectopy, atrial tachycardia and AV block.
They also follow an actual clinical case to map atrial tachycardia, in order to successfully restore sinus rhythm in these patients.
Preclinical data show that DTI-0009 is rate-selective such that it has no activity under conditions of normal heart rate, but exerts a powerful inhibitory action on conduction of electrical impulses during episodes of atrial tachycardia.
Supraventricular tachycardia (SVT), paroxysmal atrial tachycardia (PAT).
The primary effectiveness endpoint is a non-inferiority comparison of treatment success as defined by both acute procedural success and chronic freedom from symptomatic paroxysmal AF, atrial tachycardia and atrial flutter; the safety endpoint is a non-inferiority comparison of early onset device-related serious adverse events.